Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Chromosomal translocation master genes, mouse models and experimental therapeutics

Abstract

Molecular biologists have elucidated general principles about chromosomal translocations by cloning oncogenes or fusion genes at chromosomal translocation junctions. These genes invariably encode intracellular proteins and in acute cancers, often involve transcription and developmental regulators, which are master regulators of cell fate (e.g. LMO2 which is involved in acute leukaemia). Chromosomal translocations are usually associated with specific cell types. The reason for this close association is under investigation using mouse models. We are trying to emulate the cell-specific consequences of chromosomal translocations in mice using homologous recombination in embryonic stem cells to generate de novo chromosomal translocations or to mimic the consequence of these translocations. In addition, chromosomal translocation genes and their products are important targets for therapy. We have designed new therapeutic strategies which include antigen-specific recruitment of endogenous cellular pathways to affect cellular viability and a novel structured form of antisense to ablate the function of fusion mRNAs. We will evaluate these procedures in the mouse models of chromosomal translocations and the long term aim is to perfect rapid procedures for characterizing patient-specific chromosomal translocations to tailor therapy to individual patients.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Agrawal A, Eastman QM, Schatz DG . 1998 Nature 399: 744–751

  • Bemark M, Neuberger MS . 2000 Oncogene 19: 3404–3410

  • Bentley DL, Rabbitts TH . 1981 Cell 24: 613–623

  • Bernheim A, Berger R, Lenoir G . 1981 Canc. Genet. Cytogenet. 3: 307–315

  • Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E, Rabbitts TH . 1988a EMBO J. 7: 385–394

  • Boehm T, Buluwela L, Williams D, White L, Rabbitts TH . 1988b EMBO J. 7: 2011–2017

  • Boehm T, Foroni L, Kaneko Y, Perutz MP, Rabbitts TH . 1991 Proc. Natl. Acad. Sci. USA 88: 4367–4371

  • Boehm T, Foroni L, Kennedy M, Rabbitts TH . 1990 Oncogene 5: 1103–1105

  • Cleary ML . 1991 Cell 66: 619–622

  • Collins EC, Pannell R, Simpson EM, Forster A, Rabbitts TH . 2000 EMBO Rep. 1: 127–132

  • Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie ANJ, King G, Rabbitts TH . 1996 Cell 85: 853–861

  • Croce CM, Shander M, Martinis J, Cicurel L, D'Ancona GG, Dolby TW, Koprowski H . 1979 Proc. Natl. Acad. Sci. USA 76: 3416–3417

  • Crozat A, Aman P, Mandahl N, Ron D . 1993 Nature 363: 640–644

  • Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM . 1982 Proc. Natl. Acad. Sci. USA 79: 7824–7827

  • de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spur NK, Heisterkamp N, Groffen J, Stephenson JR . 1982 Nature 300: 765–767

  • Delassus S, Titley I, Enver T . 1999 Blood 94: 1495–1503

  • Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, Corral J, Smith AJH, Rabbitts TH . 1999 EMBO J. 18: 3564–3574

  • Dobson CL, Warren AJ, Pannell R, Forster A, Rabbitts TH . 2000 EMBO J. 19: 843–851

  • Drynan LF, Hamilton TL, Rabbitts TH . 2001 Oncogene in press

  • Dube ID, Kamel-Reid S, Yuan CC, Lu M, Wu X, Corpus G, Raimondi SC, Crist WM, Carroll AJ, Minowada J, Baker JB . 1991 Blood 78: 2996–3003

  • Fisch P, Boehm T, Lavenir I, Larson T, Arno J, Forster A, Rabbitts TH . 1992 Oncogene 7: 2389–2397

  • Fischer A, Malissen B . 1998 Science 280: 237–243

  • Grutz G, Bucher K, Lavenir I, Larson R, Larson T, Rabbitts TH . 1998 EMBO J. 17: 4594–4605

  • Hanahan D, Folkman J . 1996 Cell 86: 353–364

  • Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ . 1991 Science 253: 79–82

  • Hiom K, Melek M, Gellert M . 1998 Cell 99: 463–470

  • Hobart MJ, Rabbitts TH, Goodfellow PN, Solomon E, Chambers S, Spurr N, Povey S . 1981 Ann. Hum. Genet. 45: 331–335

  • Jacobson RH, Zhang X-J, DuBose RF, Matthews BW . 1994 Nature 369: 761–766

  • Kennedy MA, Gonzalez-Sarmiento R, Kees UR, Lampert F, Dear N, Boehm T, Rabbitts TH . 1991 Proc. Natl. Acad. Sci. USA 88: 8900–8904

  • Klein G . 1981 Nature 294: 313–318

  • Kovacs G, Szucs S, De Riese W, Baumgartel H . 1987 Int. J. Cancer 40: 171–178

  • Larson R, Fisch P, Larson T, Lavenir I, Langford T, King G, Rabbitts TH . 1994 Oncogene 9: 3675–3681

  • Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH . 1996 EMBO J. 15: 1021–1027

  • Larson RC, Osada H, Larson TA, Lavenir I, Rabbitts TH . 1995 Oncogene 11: 853–862

  • Lu M, Gong Z, Shen W, Ho AD . 1991 EMBO J. 10: 2905–2910

  • Ma Q, Alder H, Nelson KK, Chatterjee D, Gu Y, Nakamura T, Canaani E, Croce CM, Siracusa LD, Buchberg AM . 1993 Proc. Natl. Acad. Sci. USA 90: 6350–6354

  • MacCorkle RA, Freeman KW, Spencer DM . 1998 Proc. Natl. Acad. Sci. USA 95: 3655–3660

  • Malcolm S, Barton P, Murphy C, Ferguson-Smith MA, Bentley DL, Rabbitts TH . 1982 Proc. Natl. Acad. Sci. USA 79: 4957–4961

  • Martineau P, Jones P, Winter G . 1998 J. Mol. Biol. 280: 117–127

  • McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien SJ, Korsmeyer SJ . 1989 Mol. Cel. Biol. 9: 2124–2132

  • Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Matteucci C, Gobbi A, Bianchini A, Colomobo E, Schiavoni I, Badaracco G, Hu X, Lazar MA, Landsberger N, Nervi C, Pelicci PG . 2000 Mol. Cell. 5: 811–820

  • Nature . 2001 Human Genome Issue Nature Publishing Group: London, UK

    Google Scholar 

  • Rabbitts TH . 1983 Biochem. Soc. Transac. 11: 119–126

  • Rabbitts TH . 1991 Cell 67: 641–644

  • Rabbitts TH . 1994 Nature 372: 143–149

  • Rabbitts TH . 1998 Genes Dev. 12: 2651–2657

  • Rabbitts TH, Bucher K, Chung G, Grütz GG, Warren AJ, Yamada Y . 1999 Cancer Res. 59: 1794s–1798s

  • Rabbitts TH, Forster A, Hamlyn PH, Baer R . 1984 Nature 309: 592–597

  • Rabbitts TH, Forster A, Larson R, Nathan P . 1993 Nature Gen. 4: 175–180

  • Rabbitts TH, Hamlyn PH, Baer R . 1983 Nature 306: 760–765

  • Rabbitts TH, Lefranc MP, Stinson MA, Sims JE, Schroder J, Steinmetz M, Spurr NL, Solomon E, Goodfellow PN . 1985 EMBO J. 4: 1461–1465

  • Royer-Pokora B, Loos U, Ludwig W-D . 1991 Oncogene 6: 1887–1893

  • Royer-Pokora B, Rogers M, Zhu T-H, Schneider S, Loos U, Bolitz U . 1995 Oncogene 10: 1353–1360

  • Sale JE, Neuberger MS . 1998 Immunity 9: 859–869

  • Sanchez-Garcia I, Kaneko Y, Gonzalez-Sarmiento R, Campbell K, White L, Boehm T, Rabbitts TH . 1991 Oncogene 6: 577–582

  • Sanchez-Garcia I, Rabbitts TH . 1994 Proc. Natl. Acad. Sci. USA 91: 7869–7873

  • Schmeichel KL, Beckerle MC . 1994 Cell 79: 211–219

  • Science. 2001 Human genome issue AACR: Washington, USA

  • Smith AJH, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts PH . 1995 Nature Genet. 9: 376–384

  • Stocks MR, Rabbitts TH . 2000 EMBO Rep. 11: 59–64

  • Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P . 1982 Proc. Natl. Acad. Sci. USA 79: 7837–7841

  • Tavladoraki P, Benvenuto E, Trinca S, De Martinis D, Cattaneo A, Galeffi P . 1993 Nature 366: 469–472

  • Tse E, Chung G, Visintin M, Catlaneo A, Rabbitts TH . 2001 Protocols for isolating antigen-specific intracellular antibody fragments as single chain Fv for use in mammalian cells. In Methods in Molecular Biology and Medicine J Walker and K Turksen. (eds) Totawa: Humana Press in press

    Google Scholar 

  • Tse E, Rabbitts TH . 2000 Proc. Natl. Acad. Sci. USA 97: 12266–12271

  • Valge-Archer VE, Osada H, Warren AJ, Forster A, Li J, Baer R, Rabbitts TH . 1994 Proc. Natl. Acad. Sci. USA 91: 8617–8621

  • van Deursen J, Fornerod M, van Rees B, Grosveld G . 1995 Proc. Natl. Acad. Sci. USA 92: 7376–7380

  • Visintin M, Tse E, Axelson H, Rabbitts TH, Cattaneo A . 1999 Proc. Natl. Acad. Sci. USA 96: 11723–11728

  • Wadman I, Li J, Bash RO, Forster A, Osada H, Rabbitts TH, Baer R . 1994 EMBO J. 13: 4831–4839

  • Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, Rabbitts TH . 1997 EMBO J. 16: 3145–3157

  • Wagner RW, Flanagan WM . 1997 Mol Med Today 3: 31–38

  • Warren AJ, Colledge WH, Carlton MBL, Evans MJ, Smith AJH, Rabbitts TH . 1994 Cell 78: 45–58

  • Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR . 1994 Ann. Rev. Imm. 12: 433–455

  • Yamada Y, Pannell R, Rabbitts TH . 2000 Proc. Natl. Acad. Sci. USA 97: 320–324

  • Yamada Y, Warren AW, Dobson C, Forster A, Pannell R, Rabbitts TH . 1998 Proc. Natl. Acad. Sci. USA 95: 3890–3895

Download references

Acknowledgements

This work was supported by the Medical Research Council.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Terence H Rabbitts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rabbitts, T. Chromosomal translocation master genes, mouse models and experimental therapeutics. Oncogene 20, 5763–5777 (2001). https://doi.org/10.1038/sj.onc.1204597

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204597

Keywords

This article is cited by

Search

Quick links